CVE-2015-4453

Description

interface/globals.php in OpenEMR 2.x, 3.x, and 4.x before 4.2.0 patch 2 allows remote attackers to bypass authentication and obtain sensitive information via an ignoreAuth=1 value to certain scripts, as demonstrated by (1) interface/fax/fax_dispatch_newpid.php and (2) interface/billing/sl_eob_search.php.

Category

5.0
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 29.07% Top 5%
Vendor Advisory jvn.jp Vendor Advisory jvn.jp Vendor Advisory open-emr.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://seclists.org/fulldisclosure/2015/Jun/48 mailing list
http://jvndb.jvn.jp/jvndb/JVNDB-2015-000092 third party advisory vendor advisory
http://packetstormsecurity.com/files/132368/OpenEMR-4.2.0-Authentication-Bypass.html
http://jvn.jp/en/jp/JVN22677713/index.html third party advisory vendor advisory
http://www.open-emr.org/wiki/index.php/OpenEMR_Patches patch vendor advisory
http://www.securityfocus.com/bid/75299 vdb entry

Frequently Asked Questions

What is the severity of CVE-2015-4453?
CVE-2015-4453 has been scored as a medium severity vulnerability.
How to fix CVE-2015-4453?
To fix CVE-2015-4453, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2015-4453 being actively exploited in the wild?
It is possible that CVE-2015-4453 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~29% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.